HSDL2 Knockdown Promotes the Progression of Cholangiocarcinoma by Inhibiting Ferroptosis through the P53/SLC7A11 Axis

Human hydroxysteroid dehydrogenase-like 2 (HSDL2) expression levels in cholangiocarcinoma cells and tissues were determined by quantitative real-time polymerase chain reaction, western blotting, and immunohistochemistry.